Analysis of JAM-A immunoprecipitates demonstrated co-association between JAM-A and a pool of AF-6 and PDZ-GEF2 but not Rap1 or β1-integrin (Figure 5a), which mirrors data acquired from MCF7 breast cancer cells (Figure 4). This evidence concerns the gene RAPGEF6 and breast carcinoma.